Ledger.Open graph →
SEC Form D · filed June 7, 2021

Aardvark Therapeutics, Inc

Offering
$30.0M
Sold
$9.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Bob Shin · San Diego, CADirectorTien-Li Lee · San Diego, CAExec · DirectorJeffrey Chi · San Diego, CADirectorZachary Hornby · San Diego, CADirectorLino D. Flores Hidalgo · Wilmington, DEExec · DirectorAlejandra T. Alvarez Aznar · Wilmington, DEDirectorIan Hossfeld · San Diego, CADirectorJerel Banks · San Diego, CADirectorHenry Ji · San Diego, CADirectorSteven J. Paggioli · New York, NYDirectorEric W. Falkeis · New York, NYExec · DirectorKathleen T. Barr · New York, NYDirectorZachary Hornby · San Diego, CADirectorJerel Banks · San Diego, CADirectorHenry Ji · Warren, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Aardvark Therapeutics, Inc. — SEC Form D filing (2021) | Ledger